about
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing its product candidate, cretostimogene grenadenorepvec, for patients with bladder cancer. The company's candidate, cretostimogene grenadenorep...
Read More
63.82
0.56
(0.89%)
516.5K
XNAS Volume
XNAS 09 Oct, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Cg Oncology Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..